404 related articles for article (PubMed ID: 17000906)
1. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents.
Camici GG; Steffel J; Akhmedov A; Schafer N; Baldinger J; Schulz U; Shojaati K; Matter CM; Yang Z; Lüscher TF; Tanner FC
Circulation; 2006 Oct; 114(14):1512-21. PubMed ID: 17000906
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design.
Steffel J; Latini RA; Akhmedov A; Zimmermann D; Zimmerling P; Lüscher TF; Tanner FC
Circulation; 2005 Sep; 112(13):2002-11. PubMed ID: 16172265
[TBL] [Abstract][Full Text] [Related]
3. Guggulsterone, an anti-inflammatory phytosterol, inhibits tissue factor and arterial thrombosis.
Gebhard C; Stämpfli SF; Gebhard CE; Akhmedov A; Breitenstein A; Camici GG; Holy EW; Lüscher TF; Tanner FC
Basic Res Cardiol; 2009 May; 104(3):285-94. PubMed ID: 18953480
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation.
Stähli BE; Camici GG; Steffel J; Akhmedov A; Shojaati K; Graber M; Lüscher TF; Tanner FC
Circ Res; 2006 Jul; 99(2):149-55. PubMed ID: 16794185
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone inhibits arterial thrombus formation and tissue factor translation.
Breitenstein A; Stämpfli SF; Camici GG; Akhmedov A; Ha HR; Follath F; Bogdanova A; Lüscher TF; Tanner FC
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2231-8. PubMed ID: 18974383
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.
Zhu S; Viswambharan H; Gajanayake T; Ming XF; Yang Z
BMC Cardiovasc Disord; 2005 Jul; 5():22. PubMed ID: 16018822
[TBL] [Abstract][Full Text] [Related]
7. Histamine induces tissue factor expression: implications for acute coronary syndromes.
Steffel J; Akhmedov A; Greutert H; Lüscher TF; Tanner FC
Circulation; 2005 Jul; 112(3):341-9. PubMed ID: 16009787
[TBL] [Abstract][Full Text] [Related]
8. Dietary α-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activation.
Holy EW; Forestier M; Richter EK; Akhmedov A; Leiber F; Camici GG; Mocharla P; Lüscher TF; Beer JH; Tanner FC
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1772-80. PubMed ID: 21571683
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance.
Wu J; Stevenson MJ; Brown JM; Grunz EA; Strawn TL; Fay WP
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):698-704. PubMed ID: 18276908
[TBL] [Abstract][Full Text] [Related]
10. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
11. DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. A novel agent for drug eluting stents?
Asmis L; Tanner FC; Sudano I; Lüscher TF; Camici GG
Biochem Biophys Res Commun; 2010 Jan; 391(4):1629-33. PubMed ID: 20035720
[TBL] [Abstract][Full Text] [Related]
12. Prothrombotic gene expression profile in vascular smooth muscle cells of human saphenous vein, but not internal mammary artery.
Payeli SK; Latini R; Gebhard C; Patrignani A; Wagner U; Lüscher TF; Tanner FC
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):705-10. PubMed ID: 18258816
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells.
Steffel J; Akhmedov A; Fähndrich C; Ruschitzka F; Lüscher TF; Tanner FC
Biochem Biophys Res Commun; 2006 Oct; 349(2):597-603. PubMed ID: 16949034
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation.
Steffel J; Hermann M; Greutert H; Gay S; Lüscher TF; Ruschitzka F; Tanner FC
Circulation; 2005 Apr; 111(13):1685-9. PubMed ID: 15795326
[TBL] [Abstract][Full Text] [Related]
15. Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells.
Llorente-Cortés V; Otero-Viñas M; Camino-López S; Llampayas O; Badimon L
Circulation; 2004 Jul; 110(4):452-9. PubMed ID: 15238452
[TBL] [Abstract][Full Text] [Related]
16. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R
Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664
[TBL] [Abstract][Full Text] [Related]
17. Laminin receptor activation inhibits endothelial tissue factor expression.
Holy EW; Stämpfli SF; Akhmedov A; Holm N; Camici GG; Lüscher TF; Tanner FC
J Mol Cell Cardiol; 2010 Jun; 48(6):1138-45. PubMed ID: 19712679
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.
Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel.
Eisenreich A; Celebi O; Goldin-Lang P; Schultheiss HP; Rauch U
Int Immunopharmacol; 2008 Feb; 8(2):307-11. PubMed ID: 18182245
[TBL] [Abstract][Full Text] [Related]
20. Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
Li Y; Minamino T; Tsukamoto O; Yujiri T; Shintani Y; Okada K; Nagamachi Y; Fujita M; Hirata A; Sanada S; Asanuma H; Takashima S; Hori M; Johnson GL; Kitakaze M
Circulation; 2005 Apr; 111(13):1672-8. PubMed ID: 15795331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
